View Future GrowthNextleaf Solutions 過去の業績過去 基準チェック /06Nextleaf Solutionsは53.8%の年平均成長率で業績を伸ばしているが、Pharmaceuticals業界はgrowingで8.8%毎年増加している。売上は成長しており、年平均29.8%の割合である。主要情報53.83%収益成長率58.54%EPS成長率Pharmaceuticals 業界の成長7.33%収益成長率29.80%株主資本利益率-33.52%ネット・マージン-13.89%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • Jun 02Second quarter 2026 earnings released: CA$0.004 loss per share (vs CA$0.002 profit in 2Q 2025)Second quarter 2026 results: CA$0.004 loss per share (down from CA$0.002 profit in 2Q 2025). Revenue: CA$2.41m (down 32% from 2Q 2025). Net loss: CA$646.3k (down 285% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.すべての更新を表示Recent updatesReported Earnings • Jun 02Second quarter 2026 earnings released: CA$0.004 loss per share (vs CA$0.002 profit in 2Q 2025)Second quarter 2026 results: CA$0.004 loss per share (down from CA$0.002 profit in 2Q 2025). Revenue: CA$2.41m (down 32% from 2Q 2025). Net loss: CA$646.3k (down 285% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Mar 03Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026.お知らせ • Jan 31Nextleaf Solutions Ltd. Auditor Raises 'Going Concern' DoubtNextleaf Solutions Ltd. filed its Annual on Jan 29, 2025 for the period ending Sep 30, 2024. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.お知らせ • Dec 26Nextleaf Solutions Ltd. Announces 14 New Product Listings Nationwide Across 4 CategoriesNextleaf Solutions Ltd. announced 14 new product listings nationally across 4 categories, and the date for their Annual General Meeting, which will be held on January 30th 2025, in Vancouver, BC. New Products and Innovation. Nextleaf announced 14 new listings under their brand Glacial Gold, across 4 categories including vapes, softgels, oils, and infused prerolls. These listings will launch between January and April 2025 nationwide. The product pipeline focuses on smokeless ingestible extracts such as softgels and oils, ready-to-consume convenience formats like All-in-One liquid diamond vapes, infused prerolls, and minor cannabinoid formulations (notably CBG and CBN) across multiple categories. These products solidify Nextleaf's market leadership in these emerging segments. Regional Product Listings. Ontario (4 new listings): Glacial Gold RSO Full Spectrum 5:5 Softgels 100-pack. Glacial Gold Atmosphere Tart Cherry CBN:THC Vape Cartridge 1.2g. Glacial Gold Atmosphere CBN:THC 15mg:15mg Oil Drops 35ml. Alberta (4 new listings: Glacial Gold Liquid Diamonds Pure Diamonds All-in-One Vape 0.95g. Glacial Gold HIGH THC Banger Cherry Bomb All-in-One Vapes 1g. Glacial Gold Atmosp Here CBN:THC 15 mg:15mg Oil Drops 35g. Glacial Gold Atmospwhere CBN:THC 15g:15mg Oil Drops 35 ml. British Columbia (6 new listings): Glacial Gold Atmosphere CBG:THC Tart Cherry Vape Cartridge 1. 2g. Glacial Gold atmospherehere CBN:THC Melon Baller Vape Cartridge1.2g. glacial Gold Atmosphere CBN;THC Oil Drops 35ml. Glacial Gold Liquid Diamonds All-in- One Vape 0.95g; Glacial Gold HIGH THC Bangers Cherry Bomb Infused Preroll 3 x 0.5g (unflavoured) Glacial Gold High THC Banger Cherry Bomb Infused Preroll3 x 0.5g.お知らせ • Dec 02Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025.お知らせ • Sep 26Nextleaf Solutions Ltd. Appoints Emma Andrews as Permanent Chief Executive OfficerNextleaf Solutions Ltd. announced the permanent appointment of Emma Andrews as the Chief Executive Officer of the Company. Andrews has acted as the Company's Interim CEO since September 8, 2023, and has been with the company for 6 years, previously as the Director of Marketing. Emma Andrews helped guide the company's commercial strategy and led the entry into consumer-packaged goods, including the company's re-launch of prohibition-era brand Glacial Gold into the regulated landscape. Andrews brings a wealth of expertise in consumer-packaged goods, having spent over 10 years leading teams, launching brands, and developing products for the natural health industry. She is a Registered Nutritionist (RHN) and certified in New Product Development (NPDP). Her most notable tenure was with plant-based nutrition company Vega, leading to a CAD 750 million acquisition by White Wave Foods in 2015.New Risk • Sep 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€8.21m market cap, or US$9.11m). Minor Risk Shareholders have been diluted in the past year (3.3% increase in shares outstanding).Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.お知らせ • Oct 21Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023.お知らせ • Sep 12+ 1 more updateNextleaf Solutions Ltd. Announces an Executive ChangeThe board of directors of Nextleaf Solutions Ltd. has announced the departure of Paul Pedersen from his role as Chief Executive Officer, effective September 08, 2023. Pedersen had been Nextleaf's CEO since inception and remains on the Board of Directors. The company announced the appointment of Emma Andrews, BA, RHN, NPDP to the role of Interim Chief Executive Officer. Andrews has worked closely with Nextleaf leadership and executive team since the company's origin, most recently as the Director of Marketing she oversaw the company's entry into branded consumer products, and was integral in creating the company's mission, vision, values, and corporate identity. Andrews has held senior management and public company executive officer roles across every vertical in the cannabis industry including cultivation/harvesting, processing, retail, ancillary, and consumer products. This is in addition to over a decade working in the Natural Products Industry to help scale emerging brands into category leaders.Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2022). Revenue: CA$2.17m (up 90% from 2Q 2022). Net loss: CA$25.2k (loss narrowed 96% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 04First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2022)First quarter 2023 results: CA$0.004 loss per share (improved from CA$0.007 loss in 1Q 2022). Revenue: CA$1.19m (up 3.3% from 1Q 2022). Net loss: CA$559.0k (loss narrowed 39% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 01Full year 2022 earnings released: CA$0.025 loss per share (vs CA$0.044 loss in FY 2021)Full year 2022 results: CA$0.025 loss per share (improved from CA$0.044 loss in FY 2021). Revenue: CA$4.41m (up 31% from FY 2021). Net loss: CA$3.49m (loss narrowed 35% from FY 2021). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 31Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 3Q 2021)Third quarter 2022 results: CA$0.007 loss per share (up from CA$0.011 loss in 3Q 2021). Revenue: CA$1.20m (up 83% from 3Q 2021). Net loss: CA$1.05m (loss narrowed 22% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 01Second quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.01 loss in 2Q 2021)Second quarter 2022 results: CA$0.004 loss per share (up from CA$0.01 loss in 2Q 2021). Revenue: CA$1.15m (up CA$1.01m from 2Q 2021). Net loss: CA$606.9k (loss narrowed 49% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.012 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$130.5k (up 24% from 2Q 2020). Net loss: CA$1.19m (loss narrowed 12% from 2Q 2020).Is New 90 Day High Low • Jan 15New 90-day high: €0.24The company is up 129% from its price of €0.10 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 19% over the same period.収支内訳Nextleaf Solutions の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:L0MA 収益、費用、利益 ( )CAD Millions日付収益収益G+A経費研究開発費31 Mar 2610-13031 Dec 251103030 Sep 251103030 Jun 251213031 Mar 251203031 Dec 2412-14030 Sep 2412-14030 Jun 2412-14031 Mar 241103031 Dec 231012030 Sep 23802030 Jun 236-12031 Mar 235-32031 Dec 224-33030 Sep 224-33030 Jun 225-53031 Mar 224-53031 Dec 213-53030 Sep 213-53030 Jun 212-63031 Mar 212-53031 Dec 202-64030 Sep 201-64030 Jun 200-65031 Mar 200-65031 Dec 190-107030 Sep 190-96030 Jun 190-85031 Mar 190-64031 Dec 180-32030 Sep 181-22030 Jun 180-21030 Sep 170-100質の高い収益: L0MAは現在利益が出ていません。利益率の向上: L0MAは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: L0MAは利益を出していないが、過去 5 年間で年間53.8%の割合で損失を削減してきた。成長の加速: L0MAの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: L0MAは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 15.3% ) と比較することは困難です。株主資本利益率高いROE: L0MAは現在利益が出ていないため、自己資本利益率 ( -33.52% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/09 04:48終値2026/06/09 00:00収益2026/03/31年間収益2025/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nextleaf Solutions Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Jun 02Second quarter 2026 earnings released: CA$0.004 loss per share (vs CA$0.002 profit in 2Q 2025)Second quarter 2026 results: CA$0.004 loss per share (down from CA$0.002 profit in 2Q 2025). Revenue: CA$2.41m (down 32% from 2Q 2025). Net loss: CA$646.3k (down 285% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2026 earnings released: CA$0.004 loss per share (vs CA$0.002 profit in 2Q 2025)Second quarter 2026 results: CA$0.004 loss per share (down from CA$0.002 profit in 2Q 2025). Revenue: CA$2.41m (down 32% from 2Q 2025). Net loss: CA$646.3k (down 285% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Mar 03Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026.
お知らせ • Jan 31Nextleaf Solutions Ltd. Auditor Raises 'Going Concern' DoubtNextleaf Solutions Ltd. filed its Annual on Jan 29, 2025 for the period ending Sep 30, 2024. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
お知らせ • Dec 26Nextleaf Solutions Ltd. Announces 14 New Product Listings Nationwide Across 4 CategoriesNextleaf Solutions Ltd. announced 14 new product listings nationally across 4 categories, and the date for their Annual General Meeting, which will be held on January 30th 2025, in Vancouver, BC. New Products and Innovation. Nextleaf announced 14 new listings under their brand Glacial Gold, across 4 categories including vapes, softgels, oils, and infused prerolls. These listings will launch between January and April 2025 nationwide. The product pipeline focuses on smokeless ingestible extracts such as softgels and oils, ready-to-consume convenience formats like All-in-One liquid diamond vapes, infused prerolls, and minor cannabinoid formulations (notably CBG and CBN) across multiple categories. These products solidify Nextleaf's market leadership in these emerging segments. Regional Product Listings. Ontario (4 new listings): Glacial Gold RSO Full Spectrum 5:5 Softgels 100-pack. Glacial Gold Atmosphere Tart Cherry CBN:THC Vape Cartridge 1.2g. Glacial Gold Atmosphere CBN:THC 15mg:15mg Oil Drops 35ml. Alberta (4 new listings: Glacial Gold Liquid Diamonds Pure Diamonds All-in-One Vape 0.95g. Glacial Gold HIGH THC Banger Cherry Bomb All-in-One Vapes 1g. Glacial Gold Atmosp Here CBN:THC 15 mg:15mg Oil Drops 35g. Glacial Gold Atmospwhere CBN:THC 15g:15mg Oil Drops 35 ml. British Columbia (6 new listings): Glacial Gold Atmosphere CBG:THC Tart Cherry Vape Cartridge 1. 2g. Glacial Gold atmospherehere CBN:THC Melon Baller Vape Cartridge1.2g. glacial Gold Atmosphere CBN;THC Oil Drops 35ml. Glacial Gold Liquid Diamonds All-in- One Vape 0.95g; Glacial Gold HIGH THC Bangers Cherry Bomb Infused Preroll 3 x 0.5g (unflavoured) Glacial Gold High THC Banger Cherry Bomb Infused Preroll3 x 0.5g.
お知らせ • Dec 02Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025.
お知らせ • Sep 26Nextleaf Solutions Ltd. Appoints Emma Andrews as Permanent Chief Executive OfficerNextleaf Solutions Ltd. announced the permanent appointment of Emma Andrews as the Chief Executive Officer of the Company. Andrews has acted as the Company's Interim CEO since September 8, 2023, and has been with the company for 6 years, previously as the Director of Marketing. Emma Andrews helped guide the company's commercial strategy and led the entry into consumer-packaged goods, including the company's re-launch of prohibition-era brand Glacial Gold into the regulated landscape. Andrews brings a wealth of expertise in consumer-packaged goods, having spent over 10 years leading teams, launching brands, and developing products for the natural health industry. She is a Registered Nutritionist (RHN) and certified in New Product Development (NPDP). Her most notable tenure was with plant-based nutrition company Vega, leading to a CAD 750 million acquisition by White Wave Foods in 2015.
New Risk • Sep 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€8.21m market cap, or US$9.11m). Minor Risk Shareholders have been diluted in the past year (3.3% increase in shares outstanding).
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
お知らせ • Oct 21Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023.
お知らせ • Sep 12+ 1 more updateNextleaf Solutions Ltd. Announces an Executive ChangeThe board of directors of Nextleaf Solutions Ltd. has announced the departure of Paul Pedersen from his role as Chief Executive Officer, effective September 08, 2023. Pedersen had been Nextleaf's CEO since inception and remains on the Board of Directors. The company announced the appointment of Emma Andrews, BA, RHN, NPDP to the role of Interim Chief Executive Officer. Andrews has worked closely with Nextleaf leadership and executive team since the company's origin, most recently as the Director of Marketing she oversaw the company's entry into branded consumer products, and was integral in creating the company's mission, vision, values, and corporate identity. Andrews has held senior management and public company executive officer roles across every vertical in the cannabis industry including cultivation/harvesting, processing, retail, ancillary, and consumer products. This is in addition to over a decade working in the Natural Products Industry to help scale emerging brands into category leaders.
Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2022). Revenue: CA$2.17m (up 90% from 2Q 2022). Net loss: CA$25.2k (loss narrowed 96% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 04First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2022)First quarter 2023 results: CA$0.004 loss per share (improved from CA$0.007 loss in 1Q 2022). Revenue: CA$1.19m (up 3.3% from 1Q 2022). Net loss: CA$559.0k (loss narrowed 39% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 01Full year 2022 earnings released: CA$0.025 loss per share (vs CA$0.044 loss in FY 2021)Full year 2022 results: CA$0.025 loss per share (improved from CA$0.044 loss in FY 2021). Revenue: CA$4.41m (up 31% from FY 2021). Net loss: CA$3.49m (loss narrowed 35% from FY 2021). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 31Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 3Q 2021)Third quarter 2022 results: CA$0.007 loss per share (up from CA$0.011 loss in 3Q 2021). Revenue: CA$1.20m (up 83% from 3Q 2021). Net loss: CA$1.05m (loss narrowed 22% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 01Second quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.01 loss in 2Q 2021)Second quarter 2022 results: CA$0.004 loss per share (up from CA$0.01 loss in 2Q 2021). Revenue: CA$1.15m (up CA$1.01m from 2Q 2021). Net loss: CA$606.9k (loss narrowed 49% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.012 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$130.5k (up 24% from 2Q 2020). Net loss: CA$1.19m (loss narrowed 12% from 2Q 2020).
Is New 90 Day High Low • Jan 15New 90-day high: €0.24The company is up 129% from its price of €0.10 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 19% over the same period.